Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicentre, Randomised, Double-Blind Study to Compare Stalevo to Levodopa/Carbidopa in Patients With Parkinson's Disease Experiencing Symptoms of Early Wearing-Off

NCT00125567 is registered in ClinicalTrials.gov with Orion Corporation, Orion Pharma as lead sponsor.

NCT NCT00125567
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00125567 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicentre, Randomised, Double-Blind Study to Compare Stalevo to Levodopa/Carbidopa in Patients With Parkinson's Disease Experiencing Symptoms of Early Wearing-Off
Lead sponsor
Orion Corporation, Orion Pharma
Phase
Phase 4
Overall status
Completed
Start date
August 31, 2005
Completion date
March 31, 2009
Enrollment
223 (actual)
Sites
19

Conditions

As the registry lists them; a condition with its own page is linked.

idiopathic parkinson's disease